Evidence map›Paper›PMID 23754215›Full record

ReviewMethods in molecular biology (Clifton, N.J.)2013

A brief history of triplet repeat diseases.

Helen Budworth, Cynthia T McMurray

Abstract readReview
In one paragraph

Review in Methods in molecular biology (Clifton, N.J.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. SV2A PET imaging in human neurodegenerative diseases.Frontiers in aging neuroscience · 2024
    Review
  12. Article
  13. Big versus small: The impact of aggregate size in disease.Protein science : a publication of the Protein Society · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Whole genome sequencing of 45 Japanese patients with intellectual disability.American journal of medical genetics. Part A · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Helen BudworthLife Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Cynthia T McMurray

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI John A. Tainer · 2001 to 2026
$89.6M
Training in Basic Research on Aging and Age-Related DiseaseT32AG000266 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Lisa M Ellerby · 1998 to 2026
$13.8M
Chemical FingerprintingR01NS060115 · NINDS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI POLYZOS, ARIS A · 2007 to 2024
$7.7M
TRAFFICKING DEFECTS IN HUNTINGTONS DISEASER01NS040738 · NINDS · MAYO CLINIC ROCHESTER · PI MCMURRAY, CYNTHIA THERESE · 2001 to 2009
$3.4M
Mismatch Repair and DNA expansionR01GM066359 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI MCMURRAY, CYNTHIA THERESE · 2004 to 2011
$2.9M
Metabolic markers for mitochondrial functionR01ES020766 · NIEHS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI MCMURRAY, CYNTHIA THERESE · 2011 to 2015
$2.3M
Age of Onset and Huntingtons DiseaseR01NS062384 · NINDS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI MCMURRAY, CYNTHIA THERESE · 2009 to 2010
$1.3M
MT Function and Dysfunction in Single Neurons in VivoRC1NS069177 · NINDS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI MCMURRAY, CYNTHIA THERESE, NORTHEN, TRENT R. · 2009 to 2010
$1.0M
NCI NIH HHS P01 CA092584NIA NIH HHS T32 AG000266NIA NIH HHS T32-AG00266NIEHS NIH HHS R01 ES020766NIGMS NIH HHS R01 GM066359NINDS NIH HHS NS060115NINDS NIH HHS NS062384NINDS NIH HHS NS069177NINDS NIH HHS NS40738NINDS NIH HHS R01 NS040738NINDS NIH HHS R01 NS060115NINDS NIH HHS R01 NS062384NINDS NIH HHS RC1 NS069177
6 · The paper itself

Abstract

Instability of repetitive DNA sequences within the genome is associated with a number of human diseases. The expansion of trinucleotide repeats is recognized as a major cause of neurological and neuromuscular diseases, and progress in understanding the mutations over the last 20 years has been substantial. Here we provide a brief summary of progress with an emphasis on technical advances at different stages.

Indexed as

Trinucleotide RepeatsAnimalsChromatinHumansNeurodegenerative DiseasesProteinsRNAChromatinProteinsRNA

Identifiers

PMID23754215
PMCPMC3913379

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.